SCHEMBL26548693

SCHEMBL26548693

Fc1ccc(-c2ccc3ccc(-c4ccc(-c5cccc6ccccc56)nc4)cc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
CYP17A1 P05093 2/20 0.40
PIM1 P11309 1/20 0.40
CYP11B1 P15538 4/20 0.39
CYP11B2 P19099 4/20 0.39
MAPK13 O15264 1/20 0.39
GCGR P47871 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
MTOR P42345 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548180 0.96 L3MBTL1 (0.46) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL26549197 0.90 PDGFRB (0.42) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL26554452 0.87 PIM1 (0.40) CYP17A1PIM1CYP11B1CYP11B2MEN1
SCHEMBL26554461 0.87 PIM1 (0.40) CYP17A1PIM1CYP11B1CYP11B2MEN1
SCHEMBL26567174 0.87 CYP11B1 (0.43) CYP17A1PIM1CYP11B1CYP11B2CYP1A2
SCHEMBL26554492 0.87 BMX (0.42) CYP17A1PIM1CYP11B1CYP11B2MEN1
SCHEMBL26564770 0.86 CYP11B1 (0.44) L3MBTL1CYP17A1PIM1CYP11B1CYP11B2
SCHEMBL26548696 0.86 TRPV1 (0.40) L3MBTL1PIM1CYP11B1CYP11B2
SCHEMBL26548688 0.83 CYP1A2 (0.48) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL26548562 0.83 CA12 (0.50) CYP17A1PIM1MAPK13GCGRMAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 CASP3 3271/4885SENP8 3394/4885SENP7 2973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.